* Intends to expand its Phase 2b storm study evaluating
activity of selinexor in multiple myeloma
The post BRIEF-Karyopharm Therapeutics provides update on Phase 2b STORM study appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Intends to expand its Phase 2b storm study evaluating
activity of selinexor in multiple myeloma
The post BRIEF-Karyopharm Therapeutics provides update on Phase 2b STORM study appeared first on NASDAQ.